Skip to content
ELIOS Vision
  • How We Address Glaucoma
  • Our Clinical Data
  • About Us
  • How We Address Glaucoma
  • Our Clinical Data
  • About Us

Addressing Glaucoma During Routine Cataract Surgery: The Experts’ Opinions on the Role of ELIOS

To understand the potential of the excimer laser-based ELIOS to improve the outcomes and quality of life of patients with glaucoma, Elios Vision Inc. held a round-table discussion with an international expert group of ophthalmologists.

Continue reading

A Vision for a New Era in Combined Glaucoma and Cataract Treatment

A Q&A with Elliot Friedman, CEO or ELIOS Vision, Inc., and Murray Johnstone, MD, a clinical professor at the University of Washington and member of the ELIOS Medical Advisory Board.

Continue reading
Linkedin-in Twitter Facebook-f Instagram

Disclaimer

ELIOS Vision GmbH is the EU distributor of ELIOS manufactured by MLase AG, located at 82110 Germering, Industriestr. 17 and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to productsurveillance@eliosvision.com.

The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices.

Caution: Investigational device – Limited by Federal (or United States) law to investigational use. ELIOS is not currently approved for use in the U.S.

© ELIOS Vision, Inc. 2022. All rights reserved. ELIOS Vision and ELIOS are trademarks of ELIOS Vision, Inc.

  • Terms & Conditions
  • Privacy Policy
  • Terms & Conditions
  • Privacy Policy